The effect of intranasal insulin administration on motor and non-motor symptoms in Parkinson’s disease patients; a randomized double-blinded placebo-controlled clinical trial
Objective: To evaluating the effect of intranasal insulin administration on motor and non-motor symptoms in Parkinson’s disease patients; a randomized double-blinded placebo-controlled clinical trial Background:…Clinic versus home dose optimization of apomorphine sublingual film in Parkinson’s Disease: cross-study comparison of safety
Objective: To compare the safety profile of clinic versus home dose optimization of apomorphine sublingual film (SL-APO) in patients with Parkinson’s disease experiencing OFF episodes.…Huntingtonism and bilateral basal ganglia hypointensity in a male with an XK variant but no McLeod red cell phenotype
Objective: To report a novel variant of XK without the characteristic RBC phenotype Background: XK disease (previously called McLeod Syndrome) is a rare X-linked disorder…Analysis of subthalamic-nuclei deep brain stimulation using radiomic feature-manifestations: a quantitative approach
Objective: To estimate STN by IPGs induced with DBS effects for Parkinson's by ‘radiomic-features(RF)’/symptoms-manifestations attained as of pre-opMRI, study possibility of ‘RF’ of amygdala-nucleus’ plus…Touchscreen nQ application as a remote digital biomarker in Parkinson disease
Objective: To characterize the viability of nQ machine learning platform via touchscreen keyboard as a digital biomarker for Parkinson disease Background: To date, a reliable…Parkinsonism and dilated ventricles: not all hydrocephalus is normal-pressure
Objective: We discuss a patient with rapidly progressive parkinsonism with radiological features of normal pressure hydrocephalus, who was diagnosed with obstructive hydrocephalus secondary to intracranial…A cross-sectional study of telemedicine use during the COVID-19 pandemic in people with Parkinson’s disease
Objective: To evaluate telemedicine (TM) use and access patterns during the COVID-19 pandemic in people with Parkinson’s disease (pwPD). Background: pwPD may experience difficulty accessing…A network imaging biomarker of X-linked dystonia-parkinsonism
Objective: To characterize a metabolic brain network associated with X-linked dystonia-parkinsonism (XDP). Background: X-linked dystonia-parkinsonism (XDP, DYT/PARK-TAF1, Lubag) is an X-linked recessive movement disorder characterized…Istradefylline effect on Parkinson’s Disease Tremor, Motor symptoms and non-Motor symptoms.
Objective: Istradefylline is FDA approved for use in patients with PD treated with carbidopa-levodopa to reduce off time. GUH Movement Disorder Group has observed that…Cerebellar ataxia as primary manifestation of HIV: a rare etiological association
Objective: We hereby report a case of subacute onset progressive pancerebellar ataxia, which after a thorough workup, turned out to be a primary manifestation of…
- « Previous Page
- 1
- …
- 120
- 121
- 122
- 123
- 124
- …
- 1374
- Next Page »